Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
31.9M
-
Shares change
-
+482K
-
Total reported value, excl. options
-
$166M
-
Value change
-
+$2.32M
-
Number of buys
-
37
-
Number of sells
-
-58
-
Price
-
$5.19
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2018
111 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2018.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.9M shares
of 52.3M outstanding shares and own 61.08% of the company stock.
Largest 10 shareholders include Evermore Global Advisors, LLC (4.75M shares), WELLINGTON MANAGEMENT GROUP LLP (4.64M shares), BlackRock Inc. (3.99M shares), RENAISSANCE TECHNOLOGIES LLC (3M shares), VANGUARD GROUP INC (2.15M shares), DIMENSIONAL FUND ADVISORS LP (2M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.73M shares), GILDER GAGNON HOWE & CO LLC (763K shares), STATE STREET CORP (739K shares), and NORTHERN TRUST CORP (546K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.